Navigation Links
Anyone can save a life: Penn researchers lead national efforts to improve CPR quality
Date:1/14/2008

PHILADELPHIA Anyone can save a life. Thats the message from physicians at the University of Pennsylvania School of Medicine.

Benjamin S. Abella, MD, MPhil, Clinical Research Director of Penns Center for Resuscitation Science and Assistant Professor of Emergency Medicine, says bystanders can play a critical role in saving lives by performing cardiopulmonary resuscitation during the 150,000 cardiac arrests that occur each year outside of hospitals in the United States. Abella served as lead author of a statement released today by the American Heart Association in the journal Circulation that outlines the ways in which communities can encourage better bystander CPR.

Too often, even people whove been trained in cardiopulmonary resuscitation are afraid to perform it because they worry theyll harm the patient by not following the right steps. Others say theyre concerned about legal liability, despite Good Samaritan laws that protect bystanders who step in to help.

Studies show that only 15 to 30 percent of sudden cardiac arrest victims receive bystander CPR before emergency personnel arrive, Abella says. But chances for survival plummet as minutes tick by without any blood circulating through the body. Early bystander CPR, however, doubles to triples survival rates.

You have to get on that chest immediately theres no time to lose, Abella says. In cardiac arrest, waiting is always more harmful than not waiting.

Penn doctors are using a multi-pronged approach, combining new technology with best clinical practices, to boost CPR quality in the community and across the nation. Among their efforts: development of innovative CPR coaching technologies for both health care professionals and lay people in the community, and creation of community-wide initiatives to train more people in CPR.

The Hospital of the University of Pennsylvania, for instance, is among only a few hospitals in the United States using a defibrillator called the MRX Q-CPR (made by Philips Medical Systems, Andover, MA), which uses a device about the size of a computer mouse to monitor CPR performance. Abella helped designed this sensor pack, which is placed on a patients chest during CPR and attached to a small defibrillator box, allowing health care workers to perform CPR over the sensor and receive instruction from the machine about how effective their chest compressions are at circulating blood through the body. The machine coaches physicians through the process, urging them to use harder or softer compressions, or compress faster or slower. In a hectic hospital environment, doctors say this automated coaching can be invaluable.

The MRX Q-CPR technology also provides a detailed transcript of CPR performance that can be used to debrief health care workers after the crisis, to better prepare them for future emergencies in the hospital.

Penn researchers have also partnered with Cardiac Science Corporation (Bothell, WA) to develop AEDs that not only administer shocks to hearts caught in dangerous rhythms, but also speak to untrained bystanders to coach them through CPR. That help is crucial to boosting cardiac arrest survival, since only half of victims can be helped by an AED, while CPR can be lifesaving for anyone. Recent Penn research shows that among untrained volunteers ages 18 to 64, the verbal coaching helped them perform compressions nearly as well and quickly as AHA guidelines recommend. Most study participants rated the prompts as very easy to understand.

This new technology is expected to hit the market within the next two years. Abella envisions that AEDs will eventually be sold as a comprehensive bundle for saving lives during cardiac emergencies, packed with the new CPR coaching technology and a kit containing gloves and a pocket mask for administering rescue breaths. Those supplies could be essential to helping bystanders fearful of infection jump into action.

If we can get ten percent of people to do CPR just because they can put on some gloves and a mask, thats ten percent more lives saved, Abella says. Defibrillators arent the only answer. Theyre not the silver bullet.

Doctors at Penn are also working with the American Heart Association to develop community-wide initiatives like Heart Safe Philadelphia, which pulls in partners from the Childrens Hospital of Philadelphia, city EMS, police and fire departments, school systems and other groups to beef up training for community members. One idea: To require that all high school seniors receive CPR training before graduation, or one day, to link training to the process of applying for a drivers license, in the model of so-called motor-voter laws that register people to vote at the Department of Motor Vehicles.

CPR training is also reaching into the home of at-risk patients once they check out of the hospital. Penn physicians have pioneered in-hospital use of the AHAs Family and Friends CPR Anytime kit, which includes a short video and an inflatable manikin for practice, to train family members when patients at risk of a cardiac event.


'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Hepatitis C Testing Recommended for Anyone with a Tattoo
2. NEWSWEEK: Cover: Health for Life: Fertility & Diet
3. Quality of life: most important predictor of survival for advanced NSCLC patients
4. Living Your Best Life: Adjusting Mind, Body and Spirit
5. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Researchers find new way to block destructive rush of immune cells
8. U of M researchers create beating heart in laboratory
9. Researchers challenge previous findings regarding widely used asthma treatment
10. UT Health Science Center researchers decoding saliva to detect breast cancer
11. Protein power: Researchers trigger insulin production in diabetic mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite ... Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on their ... experience. , BOC Global Events & Training Group is a professional event and ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an ... not a one hour a week showing of hands. “The Road To Restoration” is ... “Perhaps you are familiar with the brass ring that you could reach out for, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Fred Rides a ... Christmas Day that follows. , “Fred Rides a Train” is the creation of ... short stories since her teen years in Michigan. The "Fred, the Dog" series is ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Eurofins Genomics today ... the College of American Pathologists (CAP) and certification ... its new laboratory in Louisville, KY ... North American headquarters. "Our new CLIA-licensed ... which is still considered the ,Gold Standard, method ...
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... 2016  Regulus Therapeutics Inc. (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... R&D day, held in New York ... anti-miR targeting microRNA-27 (miR-27) for the treatment of ... anti-miR targeting microRNA-17 (miR-17) for the treatment of ...
Breaking Medicine Technology: